Novavax (NVAX) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended December 2023, Novavax (NVAX) reported revenue of $291.34 million, down 18.5% over the same period last year. EPS came in at -$ 1.44, compared to - $2.28 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of$ 334.46 million, representing a surprise of -12.89%. The company delivered an EPS surprise of -193.88%, with the consensus EPS estimate being -$0.49.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...